Pathway analysis showed that these DE genes were significantly enriched in several cancer-related pathways, such as the PI3K-Akt signaling pathway, metabolic pathways, the p53 signaling pathway, the TGF-beta signaling pathway, and pathways regulating the pluripotency of stem cells. The gene discussed is TP53; the disease is cancer.